Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
811K
-
Shares change
-
+551K
-
Total reported value, excl. options
-
$36.4M
-
Value change
-
+$25.4M
-
Number of buys
-
25
-
Number of sells
-
-9
-
Price
-
$44.94
Significant Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q2 2021
36 filings reported holding GLSI - Greenwich LifeSciences, Inc. - COM as of Q2 2021.
Greenwich LifeSciences, Inc. - COM (GLSI) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 811K shares
.
Largest 10 shareholders include Invesco Ltd. (280K shares), BlackRock Inc. (218K shares), VANGUARD GROUP INC (121K shares), GEODE CAPITAL MANAGEMENT, LLC (52.4K shares), STATE STREET CORP (50.2K shares), NORTHERN TRUST CORP (12.1K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (9.82K shares), MORGAN STANLEY (8.4K shares), SkyOak Wealth, LLC (7.39K shares), and Bank of New York Mellon Corp (6.66K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.